Sign in

CIK 0001776111 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

MBX Biosciences, Inc.

Sign in to watch
Ticker
MBX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
3179893100
Business address
11711 N. MERIDIAN STREET, SUITE 300, CARMEL, IN, 46032
  1. SCHEDULE 13D/A Stake Beneficial Ownership Report
  2. SCHEDULE 13D/A Stake Beneficial Ownership Report
  3. SCHEDULE 13D/A Stake Beneficial Ownership Report
  4. 4 Insider Changes in Ownership
  5. 8-K Event Material agreement
  6. 424B4 Offering Prospectus
  7. EFFECT Other Notice of Effectiveness
  8. S-1MEF Other S-1MEF
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. S-1 Offering Registration Statement
  12. 8-K Event Regulation FD disclosure · Other events
  13. 8-K Event Regulation FD disclosure · Other events
  14. SCHEDULE 13D/A Stake Beneficial Ownership Report
  15. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  16. UPLOAD Other SEC-generated Letter
  17. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  18. DRS Other Draft Registration Statement
  19. 10-Q Report Quarterly Report
  20. 8-K Event Results of operations

Page 6 of 12 · 237 filings